Proton-Pump Inhibitor as Palliative Care for Chemotherapy-Induced Gastroesophageal Reflux Disease in Pancreatic Cancer Patients

被引:11
|
作者
Uwagawa, Tadashi [1 ]
Misawa, Takeyuki [1 ]
Iida, Tomonori [1 ]
Sakamoto, Taro [1 ]
Gocho, Takeshi [1 ]
Wakiyama, Shigeki [1 ]
Hirohara, Shoichi [1 ]
Yanaga, Katsuhiko [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
关键词
RECOMMENDATIONS; GUIDELINES; THERAPY;
D O I
10.1089/jpm.2009.0404
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Relief of adverse events induced by chemotherapy is an important issue for patients, especially those with a poor prognosis, such as with pancreatic cancer. There are no reports of the relationship between gastroesophageal reflux disease (GERD) and chemotherapy, so we investigated the incidence of chemotherapy-induced GERD in patients undergoing treatment with gemcitabine or S-1 for pancreatic cancer and the effect of sodium rabeprazole (RPZ), a proton-pump inhibitor. GERD was diagnosed in 40% of the patients according to the Frequency Scale for Symptoms of GERD score, and RBZ therapy significantly improved their symptoms.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 50 条
  • [21] Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
    Cheng, Yuan
    Liu, Jiali
    Tan, Xiang
    Dai, Yi
    Xie, Chune
    Li, Xiaohong
    Lu, Qiongqiong
    Kou, Fushun
    Jiang, Hui
    Li, Junxiang
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (01) : 19 - 28
  • [22] Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease
    Penagini, Roberto
    Sweis, Rami
    Mauro, Aurelio
    Domingues, Gerson
    Vales, Andres
    Sifrim, Daniel
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 21 (02) : 265 - 272
  • [23] Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors
    Kristo, Ivan
    Schwameis, Katrin
    Maschke, Svenja
    Kainz, Alexander
    Rieder, Erwin
    Paireder, Matthias
    Jomrich, Gerd
    Schoppmann, Sebastian F.
    SCIENTIFIC REPORTS, 2018, 8
  • [24] A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease
    Simadibrata, Daniel Martin
    Lesmana, Elvira
    Fass, Ronnie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (05) : 796 - 805
  • [25] Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study
    Jonasson, Christian
    Tvete, Ingunn F.
    Hatlebakk, Jan G.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 1010 - 1017
  • [26] Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial
    Cho, Jae Ho
    Shin, Cheol Min
    Yoon, Hyuk
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [27] Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study)
    Lu, Bin
    Zhang, Ling
    Wang, Jiangbin
    Wang, Bangmao
    Zou, Xiaoping
    Fei, Guijun
    Chen, Dongfeng
    Wang, Xuehong
    Wu, Bin
    Zou, Duowu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (10) : 1722 - 1727
  • [28] Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis
    Chen, C. -H.
    Lin, C. -L.
    Kao, C. -H.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (06) : 2117 - 2126
  • [29] Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region
    Goh, Khean Lee
    Choi, Myung Gyu
    Hsu, Ping I.
    Chun, Hoon Jai
    Mahachai, Varocha
    Kachintorn, Udom
    Leelakusolvong, Somchai
    Kim, Nayoung
    Rani, Abdul Aziz
    Wong, Benjamin C. Y.
    Wu, Justin
    Chiu, Cheng Tang
    Shetty, Vikram
    Bocobo, Joseph C.
    Chan, Melchor M.
    Lin, Jaw-Town
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (03) : 355 - 366
  • [30] Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring
    Kohata, Yukie
    Fujiwara, Yasuhiro
    Machida, Hirohisa
    Okazaki, Hirotoshi
    Yamagami, Hirokazu
    Tanigawa, Tetsuya
    Watanabe, Kenji
    Watanabe, Toshio
    Tominaga, Kazunari
    Arakawa, Tetsuo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 58 - 62